Android app on Google Play

Abiomed (ABMD) Reports In-Line Q3 EPS

February 6, 2013 7:20 AM EST Send to a Friend
Abiomed, Inc. (NASDAQ: ABMD) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $38.3 million versus the consensus estimate of $38.04 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment